1.55
9.93%
0.14
Salarius Pharmaceuticals Inc (SLRX) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
-
|
- | - | - | - |
Operating Expenses
|
82.51%
1.7716
|
0.9707 | 2.5322 | 3.9714 | 5.4207 |
Operating Income/Loss |
82.51%
-1.7716
|
-0.9707 | -2.5322 | -3.9714 | -5.4207 |
Income/Loss From Continuing Operations Before Tax |
94.52%
-1.7153
|
-0.8818 | -2.4428 | -3.8773 | -5.3408 |
Income/Loss From Continuing Operations After Tax |
94.52%
-1.7153
|
-0.8818 | -2.4428 | -3.8773 | -5.3408 |
Net Income/Loss
|
94.52%
-1.7153
|
-0.8818 | -2.4428 | -3.8773 | -5.3408 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
1,747%
4.1946
|
0.2271 | 3.754 | 2.7091 | 2.392 |
Diluted Average Shares |
1,747%
4.1946
|
0.2271 | 3.754 | 2.7091 | 2.392 |
Basic Earnings Per Share |
-0.41
|
- | -0.65 | -1.43 | -2.23 |
Diluted Earnings Per Share |
-0.41
|
- | -0.65 | -1.43 | -2.23 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):